- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Deutsch
- Bibliographic citation
-
CD23-positive, BCL2-Rearrangement-negative Keimzentrumslymphome ; volume:44 ; number:3 ; day:6 ; month:11 ; year:2023 ; pages:160-163 ; date:12.2023
Die Pathologie ; 44, Heft 3 (6.11.2023), 160-163, 12.2023
- Creator
-
Menter, Thomas
Quintanilla-Martinez, Leticia
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00292-023-01250-0
- URN
-
urn:nbn:de:101:1-2024030613293079490252
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Menter, Thomas
- Quintanilla-Martinez, Leticia
- SpringerLink (Online service)
Other Objects (12)
Targeted inhibition of DHODH is synergistic with BCL2 blockade in HGBCL with concurrent MYC and BCL2 rearrangement
Detection of Protein BCL2/JH Rearrangement in Epidermoid Carcinomas of Mouth and Pharynx
Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing
Primary follicular lymphoma of the epididymis positive for t(14;18)(q32;q21)/IGH- BCL2 and negative for BCL2 protein expression: a case report
Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2
Bcl2 inhibition of mitochondrial DNA repair
BCL2 genotypes and prostate cancer survival
positiv – negativ
Negativ und Positiv
Negativ und Positiv
Negativ-Positiv-Kombination
A BCL2 promoter polymorphism rs2279115 is not associated with BCL2 protein expression or patient survival in breast cancer patients
Targeted inhibition of DHODH is synergistic with BCL2 blockade in HGBCL with concurrent MYC and BCL2 rearrangement
Detection of Protein BCL2/JH Rearrangement in Epidermoid Carcinomas of Mouth and Pharynx
Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing
Primary follicular lymphoma of the epididymis positive for t(14;18)(q32;q21)/IGH- BCL2 and negative for BCL2 protein expression: a case report
Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2
Bcl2 inhibition of mitochondrial DNA repair
BCL2 genotypes and prostate cancer survival
positiv – negativ
Negativ und Positiv
Negativ und Positiv
Negativ-Positiv-Kombination
A BCL2 promoter polymorphism rs2279115 is not associated with BCL2 protein expression or patient survival in breast cancer patients
Targeted inhibition of DHODH is synergistic with BCL2 blockade in HGBCL with concurrent MYC and BCL2 rearrangement
Detection of Protein BCL2/JH Rearrangement in Epidermoid Carcinomas of Mouth and Pharynx
Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing
Primary follicular lymphoma of the epididymis positive for t(14;18)(q32;q21)/IGH- BCL2 and negative for BCL2 protein expression: a case report
Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2
Bcl2 inhibition of mitochondrial DNA repair
BCL2 genotypes and prostate cancer survival
positiv – negativ
Negativ und Positiv
Negativ und Positiv
Negativ-Positiv-Kombination